Mayzent (Siponimod) for Multiple Sclerosis

Overview
Mayzent is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. Mayzent is also referred to by its drug name, Siponimod.

Mayzent is an immunomodulator, in other words, a drug that modulates the immune system. Mayzent is believed to work by reducing the number of lymphocytes (white blood cells) in the bloodstream, preventing them from contributing to the autoimmune attack on the nervous system.

How do I take it?
Mayzent is taken orally once a day.

Mayzent is available as a tablet.

Side effects
Common side effects listed for Mayzent include headache and hypertension (high blood pressure).

Rare but serious side effects listed for Mayzent include infections, macular edema (swelling inside the eye), decreased heart rate, breathing problems, increased risk of developing lymphoma, increased blood pressure, and risk of fetal harm in pregnant women.

For more details about this treatment, visit:
Mayzent - Novartis
https://www.mayzent.com/